Latest in Research & Development

Gilead opens $32bn-backed research hub to accelerate oncology and inflammation pipeline

The 182,000 sq ft Foster City facility co-locates oncology, inflammation and data science teams as part of the firm's wider US manufacturing and R&D investment drive

Find out more
Gilead opens $32bn-backed research hub to accelerate oncology and inflammation pipeline

OutSee secures £50,000 Innovate UK grant for agentic AI drug target validation pilot

OutSee secures £50,000 Innovate UK grant for agentic AI drug target validation pilot

OutSee will use Innovate UK and Empirical Ventures funding to develop an agentic AI sub-system designed to accelerate initial validation of drug targets identified by its...
See more
From drug substance to drug product: why integration matters in modern pharmaceutical development

From drug substance to drug product: why integration matters in modern pharmaceutical development

Pharmaceutical development is becoming increasingly complex. More challenging molecules, compressed timelines, evolving regulatory expectations and the need for resilient supply chains are placing greater pressure on development and manufacturing teams to make the right decisions earlier
Novartis and BMS slam breaks on gene therapy trials after adverse events

Novartis and BMS slam breaks on gene therapy trials after adverse events

Three patients have reportedly died in Novartis' experimental trials of its CAR-T therapy for autoimmune conditions, causing the pharma giant to halt eight of its clinical trials, with BMS pausing enrollment for its own CAR-T treatment for similar issues
Akiram and ITM sign supply agreement to develop AKIR001 to treat solid tumours

Akiram and ITM sign supply agreement to develop AKIR001 to treat solid tumours

AKIR001 is a targeted antibody-radionuclide conjugate designed to deliver radiation directly to CD44v6-expressing solid tumours, with potential to become a first-in-class therapy
Lupin advances speciality pipeline with FDA approval and European partnership

Lupin advances speciality pipeline with FDA approval and European partnership

Lupin has recently announced two significant developments, reinforcing its momentum in both the US generics market and its global speciality care strategy
Jocasta expands UCSF α-klotho licence ahead of 2027 Phase I trial

Jocasta expands UCSF α-klotho licence ahead of 2027 Phase I trial

Jocasta Neuroscience has secured expanded exclusive rights to UCSF α-klotho intellectual property as it advances JN-0413 towards first-in-human testing for cognitive impairment and neurodegenerative disease
SynGenSys introduces expanded CHO.SET synthetic promoter library for enhanced biomanufacturing

SynGenSys introduces expanded CHO.SET synthetic promoter library for enhanced biomanufacturing

CHO.SET 2.0 library of synthetic promoters provide tuneable expression of transgenes whilst maximising CHO cell productivity
Hanmi licenses UCN2 obesity drug candidate HM17321 to Genentech in $2.3bn deal

Hanmi licenses UCN2 obesity drug candidate HM17321 to Genentech in $2.3bn deal

Hanmi Pharm has granted Genentech global rights to develop and commercialise HM17321, an investigational UCN2 analogue designed to drive weight loss while preserving lean mass
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

Latest posts in Research & Development

First commercial kidney transplant patient treated with Idefirix in Australia

First commercial kidney transplant patient treated with Idefirix in Australia

Imlifidase is an antibody-cleaving enzyme originating from Streptococcus pyogenes that specifically targets and cleaves immunoglobulin G (IgG) antibodies and inhibits IgG-mediated immune response
CEPI announces $4.17m for studies assessing existing Ebola vaccines against Bundibugyo strain

CEPI announces $4.17m for studies assessing existing Ebola vaccines against Bundibugyo strain

Four CEPI-backed research projects will analyse thousands of stored blood samples to determine whether vaccines against Zaire ebolavirus, including Ervebo, generate immune responses to Bundibugyo ebolavirus
FairJourney Bio engineers tumour-conditional IL-12 switch to improve therapeutic window

FairJourney Bio engineers tumour-conditional IL-12 switch to improve therapeutic window

The company has engineered a dual-specificity antibody fragment designed to activate IL-12 selectively in the tumour microenvironment, with preclinical data and quantitative systems pharmacology modelling indicating potential for reduced systemic toxicity
MedPharm expands proteomic analysis capabilities with Olink certification

MedPharm expands proteomic analysis capabilities with Olink certification

MedPharm has become an Olink Certified Service Provider, adding multiplex proteomic analysis to its end-to-end drug development and human tissue research capabilities
Ryvu launches Keelira to support biotech and pharma companies with European Phase I/II development

Ryvu launches Keelira to support biotech and pharma companies with European Phase I/II development

Ryvu Therapeutics has launched Keelira, a dedicated clinical development services business supporting biotech and pharma companies with Phase I and II oncology programmes across European markets
University of Birmingham develops "switchable smart gel" that could revolutionise targeted drug delivery

University of Birmingham develops "switchable smart gel" that could revolutionise targeted drug delivery

The multi-responsive material switches between gel and liquid states under UV light or acid exposure, with acid-triggered release mechanisms offering a potential platform for site-specific drug delivery in diseased tissue
Andelyn Biosciences partners with Queen's University Belfast for GM2 Gangliosides candidate

Andelyn Biosciences partners with Queen's University Belfast for GM2 Gangliosides candidate

The CGT company will use its Curator Platform to advance AAV9-GM2 towards patient dosing through a multiphase programme, supporting the University in bringing the potentially "life-changing therapy" to patients
Panthera opens clinical research site at Keele University

Panthera opens clinical research site at Keele University

Panthera has opened a new clinical trial site at Keele University, expanding its UK and European research network to 11 locations and increasing access to clinical studies in Staffordshire
Amgen announces new Science and Innovation Center in Hyderabad to bolster R&D

Amgen announces new Science and Innovation Center in Hyderabad to bolster R&D

The new hub will open next year and forms part of a growing community of pharma giants choosing Genome Valley as a base for their research facilities
Calla Lily Clinical Care joins $50m programme to develop UTI treatment

Calla Lily Clinical Care joins $50m programme to develop UTI treatment

The vaginal drug delivery specialist has been selected by Wellcome Leap to advance a targeted UTI treatment as part of a new programme addressing antimicrobial resistance
You need to be a subscriber to read this article.
Click here to find out more.
Fridge-free tetanus-diphtheria vaccine passes first human trial

Fridge-free tetanus-diphtheria vaccine passes first human trial

Stablepharma's SPVX02 vaccine remains stable at 30°C for two years, new Phase I data shows, easing cold-chain dependence

Sponsor content

OEB 7 isolators: raising the standard for ultra-potent API containment

OEB 7 isolators: raising the standard for ultra-potent API containment

As ultra-potent APIs reach increasingly low exposure limits, OEB 7 containment is becoming critical. Discover how advanced isolators support safer, more efficient...
Lonza strengthens US manufacturing with new commercial spray-drying facility

Lonza strengthens US manufacturing with new commercial spray-drying facility

Bend, Oregon facility will expand commercial-scale spray-drying capacity and create more than 80 new jobs
ADC manufacturing: tackling containment challenges across pharma production

ADC manufacturing: tackling containment challenges across pharma production

Explore the containment challenges of ADC production, from cytotoxic payloads and conjugation to aseptic fill-finish, and how high-containment isolators help protect...
From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology

From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology

By integrating GEA granulation technology into its new facility, Beta Pharmacon has enhanced process control, reinforced its commitment to regulatory compliance, and...
Visit Lonza at CPHI Booth 6F2: advance your molecule to market faster

Visit Lonza at CPHI Booth 6F2: advance your molecule to market faster

Meet Lonza experts at CPHI Booth 6F2 for coffee and insights, and discover integrated solutions and strategies to bring complex therapies to market faster and smarter
Syntegon at CPHI: seamless solutions for liquid and solid pharmaceuticals

Syntegon at CPHI: seamless solutions for liquid and solid pharmaceuticals

At CPHI Milan (booth 9A50), Syntegon will underline why holistic vial lines reduce interfaces and complexity, and how the new common HMI for OSD equipment supports easier...
Thermo Fisher Scientific launches Multiskan Ease absorbance microplate reader

Thermo Fisher Scientific launches Multiskan Ease absorbance microplate reader

Dedicated absorbance reader helps academic, biotech, pharmaceutical and quality control labs generate reliable data for common biological assays with straightforward...
GEA strengthens competence centre for mechanical separation technology

GEA strengthens competence centre for mechanical separation technology

Process Test Centre at Oelde site to be expanded
Bio-Rad expands Foresight Pro prepacked chromatography columns with Nuvia ion exchange and mixed-mode resins

Bio-Rad expands Foresight Pro prepacked chromatography columns with Nuvia ion exchange and mixed-mode resins

Extended range of process-scale columns prepacked with CEX, AEX, CEX-HIC and AEX-HIC chromatography resins provides an effective solution for purification of biomolecules...
Accelerate your path to IND

Accelerate your path to IND

BioDuro brings Drug Substance, Drug Product, DMPK, Pharmacology and Toxicology together in one integrated IND-enabling solution, helping you reduce handoffs, avoid delays...
Shaping the future of pharma: GELITA’s next-gen excipients at CPHI

Shaping the future of pharma: GELITA’s next-gen excipients at CPHI

From advanced softgels to endotoxin-controlled bioscience excipients, GELITA is showcasing technologies at CPHI 2026 that will help shape the next generation of...
Overcoming key pharmaceutical formulation challenges with liquid-filled hard capsules

Overcoming key pharmaceutical formulation challenges with liquid-filled hard capsules

Liquid-filled capsules address common formulation challenges, from improving bioavailability to enhancing stability and dosing accuracy

Featured companies

As a dedicated CDMO serving the healthcare industry, we bring life-enhancing and life-saving treatments to market for our customers and their patients. We are a pioneer and... At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable. Since 1974, Butterworth Laboratories has provided independent, contract analytical chemistry services to the global pharmaceutical and related industries. Consequently, we are... GEA is a leading provider of process technology and complete production lines for the pharmaceutical, biopharmaceutical, biotechnology and nutraceutical industries, spanning...
See more